BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Proteon Therapeutics, Inc. 

4420 Madison Avenue
Suite 180
Kansas City  Missouri  64111  U.S.A.
Phone: 816-531-0028 Fax: 816-531-3079


SEARCH JOBS




Industry
Biotechnology






 Company News
Boston's Proteon Therapeutics, Inc. Files For $61 Million IPO 10/22/2014 6:08:08 AM
Moving On From A Botched Novartis AG (NVS) Deal, Proteon Therapeutics, Inc. Turns To Plan B: IPO 9/17/2014 6:45:17 AM
Proteon Therapeutics, Inc. Initiates Phase 3 Clinical Study Of PRT-201 In Patients With Chronic Kidney Disease Undergoing Surgical Placement Of An Arteriovenous Fistula For Hemodialysis 7/21/2014 11:14:02 AM
Proteon Therapeutics, Inc. Announces $45 Million Of Series D Financing 5/16/2014 7:19:26 AM
Proteon Therapeutics, Inc. Announces Publication Of Results From Phase 2 Study Of PRT-201 5/14/2014 8:35:52 AM
Proteon Therapeutics, Inc., Looking Past Ill-Fated Novartis AG (NVS) Deal, Goes It Alone 3/18/2014 7:33:36 AM
Proteon Therapeutics, Inc. Announces Orphan Drug Designation In The European Union For PRT-201 1/8/2014 10:20:52 AM
Proteon Therapeutics, Inc. Announces Positive Phase 2 Trial Results of PRT-201 in Chronic Kidney Disease Patients Undergoing Surgical Placement of an Arteriovenous Fistula for Hemodialysis 1/4/2013 9:52:43 AM
Awaiting Novartis AG Acquisition, Biotech Firm Proteon Therapeutics, Inc. Raises $15.2 Million 8/12/2011 8:04:43 AM
Proteon Therapeutics, Inc. Initiates Patient Enrollment in Phase 2 Clinical Study of PRT-201 in Hemodialysis Patients 4/14/2011 12:38:48 PM
123